CHARACTERIZATION OF HUMAN PROLIFERATIVE T-CELL RESPONSES TO ADENOVIRUS

被引:110
作者
FLOMENBERG, P
PIASKOWSKI, V
TRUITT, RL
CASPER, JT
机构
[1] MED COLL WISCONSIN, DEPT MED, MILWAUKEE, WI 53226 USA
[2] MED COLL WISCONSIN, DEPT PEDIAT, MILWAUKEE, WI 53226 USA
[3] JOHN L DOYNE HOSP, MILWAUKEE, WI USA
[4] CHILDRENS HOSP WISCONSIN, MILWAUKEE, WI 53201 USA
关键词
D O I
10.1093/infdis/171.5.1090
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although cellular immune responses are likely important for recovery from acute adenovirus infection, they have not been studied in humans, As a first step, a sensitive assay for the detection of adenovirus-specific proliferative T cell responses was developed. Peripheral blood mononuclear cells from 29 of 30 healthy adults exhibited specific proliferative responses to adenovirus type 2 antigen. Adenovirus-specific proliferation was found to be mediated by CD4(+) T cells. Specific proliferative responses were detected to purified Ad2 virions and by Ad2-infected cell lysates, indicating that adenovirus structural proteins are important targets, In addition, specific proliferative responses to the uncommon adenovirus type 35 were found in persons without serologic evidence of prior Ad35 infection, These data suggest that adenovirus-specific CD4(+) T cells recognize conserved antigens among different serotypes and that a majority of persons develop long-lived CD4(+) T cell responses to adenovirus.
引用
收藏
页码:1090 / 1096
页数:7
相关论文
共 42 条
[1]   IMPAIRED INTRACELLULAR-TRANSPORT OF CLASS-I MHC ANTIGENS AS A POSSIBLE MEANS FOR ADENOVIRUSES TO EVADE IMMUNE SURVEILLANCE [J].
ANDERSSON, M ;
PAABO, S ;
NILSSON, T ;
PETERSON, PA .
CELL, 1985, 43 (01) :215-222
[2]  
BELLGRAU D, 1985, J VIROL, V62, P1531
[3]  
BEVERLEY PCL, 1989, PROGR IMMUNOLOGY, V7, P432
[4]   AN ADENOVIRUS TYPE-2 GLYCOPROTEIN BLOCKS CELL-SURFACE EXPRESSION OF HUMAN HISTOCOMPATIBILITY CLASS-I ANTIGENS [J].
BURGERT, HG ;
KVIST, S .
CELL, 1985, 41 (03) :987-997
[5]   SEVERE AND FATAL PNEUMONIA IN INFANTS AND YOUNG CHILDREN ASSOCIATED WITH ADENOVIRUS INFECTIONS [J].
CHANY, C ;
LEPINE, P ;
LELONG, M ;
VINH, LT ;
SATGE, P ;
VIRAT, J .
AMERICAN JOURNAL OF HYGIENE, 1958, 67 (03) :367-378
[6]   INCREASING INCIDENCE OF ADENOVIRUS DISEASE IN BONE-MARROW TRANSPLANT RECIPIENTS [J].
FLOMENBERG, P ;
BABBITT, J ;
DROBYSKI, WR ;
ASH, RC ;
CARRIGAN, DR ;
SEDMAK, GV ;
MCAULIFFE, T ;
CAMITTA, B ;
HOROWITZ, MH ;
BUNIN, N ;
CASPER, JT .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (04) :775-781
[7]   MOLECULAR EPIDEMIOLOGY OF ADENOVIRUS TYPE-35 INFECTIONS IN IMMUNOCOMPROMISED HOSTS [J].
FLOMENBERG, PR ;
MEI, C ;
MUNK, G ;
HORWITZ, MS .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (06) :1127-1134
[8]   SEATTLE VIRUS WATCH .7. OBSERVATIONS OF ADENOVIRUS INFECTIONS [J].
FOX, JP ;
HALL, CE ;
COONEY, MK .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1977, 105 (04) :362-386
[9]   ADENOVIRUS-TYPE-12 E1A GENE REPRESSES ACCUMULATION OF MHC CLASS-I MESSENGER-RNAS AT THE LEVEL OF TRANSCRIPTION [J].
FRIEDMAN, DJ ;
RICCIARDI, RP .
VIROLOGY, 1988, 165 (01) :303-305
[10]   ROLE OF EARLY REGION-3 (E3) IN PATHOGENESIS OF ADENOVIRUS DISEASE [J].
GINSBERG, HS ;
LUNDHOLMBEAUCHAMP, U ;
HORSWOOD, RL ;
PERNIS, B ;
WOLD, WSM ;
CHANOCK, RM ;
PRINCE, GA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (10) :3823-3827